Literature DB >> 16356474

Free fatty acids administered into the colon promote the secretion of glucagon-like peptide-1 and insulin.

Tetsuya Adachi1, Toshiki Tanaka, Kazuhisa Takemoto, Taka-aki Koshimizu, Akira Hirasawa, Gozoh Tsujimoto.   

Abstract

We examined whether free fatty acids (FFAs) promote glucagon-like peptide-1 (GLP-1) secretion when administered into the intestinal tract. We found that an unsaturated long-chain FFA, alpha-linolenic acid (alpha-LA), resulted in increased plasma GLP-1 and insulin levels when administered into the colon. Such stimulatory effects were not apparent with either vehicle or a saturated middle-chain FFA, octanoic acid (OA). Concomitant with GLP-1 secretion, the administration of alpha-LA, but not vehicle or OA, also resulted in a significant increase in the population of pERK positive cells within the GLP-1 positive cells of the colonic mucosa. Moreover, colonic administration of alpha-LA into normal C3H/He mice caused a reduction in plasma glucose levels, as well as in type 2 diabetic model NSY mice. Our results indicate that the in vivo colonic administration of alpha-LA promotes secretion of incretin GLP-1 by activating the ERK pathway in L-cells and thereby enhances the secretion of insulin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16356474     DOI: 10.1016/j.bbrc.2005.11.162

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

Review 1.  Dietary Lipids Inform the Gut and Brain about Meal Arrival via CD36-Mediated Signal Transduction.

Authors:  Sinju Sundaresan; Nada A Abumrad
Journal:  J Nutr       Date:  2015-08-12       Impact factor: 4.798

2.  Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?

Authors:  Undurti N Das
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-02       Impact factor: 5.555

3.  Chylomicron formation and secretion is required for lipid-stimulated release of incretins GLP-1 and GIP.

Authors:  Wendell J Lu; Qing Yang; Li Yang; Dana Lee; David D'Alessio; Patrick Tso
Journal:  Lipids       Date:  2012-06       Impact factor: 1.880

4.  The correlation between intestinal gonadotropin-releasing hormone (GnRH) and proglucagon in hyperlipidemic rats and Goto-Kakizaki (GK) rats.

Authors:  Li Wang; Jing Wu; Hongwei Cao; Rong Chen; Nanyan Zhang; Jianfang Fu; Bin Gao; Jing Zhang; Rongrong Hou; Chaowu Tang; Qiuhe Ji
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

5.  Docosahexaenoic acid has an anti-diabetic effect in streptozotocin-induced diabetic mice.

Authors:  Ping Li; Li Zhang; Xin Tian; Jie Xing
Journal:  Int J Clin Exp Med       Date:  2014-09-15

6.  Denatonium induces secretion of glucagon-like peptide-1 through activation of bitter taste receptor pathways.

Authors:  Ki-Suk Kim; Josephine M Egan; Hyeung-Jin Jang
Journal:  Diabetologia       Date:  2014-07-13       Impact factor: 10.122

7.  Free fatty acids induce cholecystokinin secretion through GPR120.

Authors:  Toshiki Tanaka; Susumu Katsuma; Tetsuya Adachi; Taka-aki Koshimizu; Akira Hirasawa; Gozoh Tsujimoto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-10-31       Impact factor: 3.000

8.  Cloning and characterization of the rat free fatty acid receptor GPR120: in vivo effect of the natural ligand on GLP-1 secretion and proliferation of pancreatic beta cells.

Authors:  Toshiki Tanaka; Takeaki Yano; Tetsuya Adachi; Taka-aki Koshimizu; Akira Hirasawa; Gozoh Tsujimoto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-03-05       Impact factor: 3.000

9.  Omega-3 and omega-6 PUFAs induce the same GPR120-mediated signalling events, but with different kinetics and intensity in Caco-2 cells.

Authors:  Kaia Mobraten; Trude M Haug; Charlotte R Kleiveland; Tor Lea
Journal:  Lipids Health Dis       Date:  2013-07-13       Impact factor: 3.876

10.  Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion.

Authors:  Sara Edfalk; Pär Steneberg; Helena Edlund
Journal:  Diabetes       Date:  2008-06-02       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.